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Supplemental Fig. S1. eQTL effect size distributions for coding and noncoding variants of each type with the 
number of eQTLs shown above the distribution. Deletions and duplications are separated by evidence used for 






























































































































Supplemental Note: Validation of MEI contribution to eQTLs 
We quantified our MEI call set by comparing the number of MEIs mapped here to a call set from a 
recent study by the Human Genome Structural Variant Consortium (HGSVC) that was generated using long-
read sequencing data (Ebert et al. 2021). We observed a mean of 1,961 MEIs per genome (median 1,528) 
while the HGSVC study mapped a mean of 1,637 MEIs per genome (median 1,258). Thus, it appears that we 
are detecting slightly more MEIs per genome despite our use of short-read WGS data, not fewer as one might 
naively expect. We believe that this is due to the fact that LUMPY and MELT are extremely good at detecting 
MEIs within relatively non-repetitive sequence, and because MEI detection is not trivial using long-read data, 
where the mapping methods are less mature. While there are some minor differences in how MEIs are 
classified based on annotations, overall, these data support the sensitivity of our MEI call set. 
We also examined the linkage disequilibrium (LD) patterns at MEIs compared to other variant types by 
measuring R2 between each SV and its most tightly linked SNV (Supplemental Fig. S2). The patterns of LD 
observed at MEIs closely mirrors the patterns observed at LUMPY deletions, and we know from extensive prior 
work that deletions are the easiest SV type to detect and genotype accurately. In contrast, other variant types 
such as tandem duplications and multi-allelic CNVs are not as well tagged due to inferior genotyping quality 




Ebert P, Audano PA, Zhu Q, Rodriguez-Martin B, Porubsky D, Bonder MJ, Sulovari A, Ebler J, Zhou W, Serra 
Mari R, et al. 2021. Haplotype-resolved diverse human genomes and integrated analysis of structural 










Supplemental Fig. S2. Distribution of linkage disequilibrium, measured by R2, between SVs detected by 


























Supplemental Fig. S3. Feature enrichment of SV-eQTLs. Fold enrichment and 95% confidence intervals 
(based on 100 random shuffled sets of the positions of SVs in each bin) for the overlap between the most 
significant SV for each eGene and various annotated genomic features. (A) Enrichment of SVs in each 
causality bin for intersections with exons of the affected eGene. (B-T) For the remaining plots, SVs that 
overlapped with an exon of the affected eGenes were excluded. Enrichment was only observed in the 10-kb 
regions upstream (N) and downstream (O) of TSSs and in segmental duplications (S), which is consistent with 
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Supplemental Fig. S4. Enrichment of SV-eQTLs in Roadmap Epigenomics segmentation states. Fold 
enrichment and 95% confidence intervals (based on 100 random shuffled sets of the positions of SVs in each 
bin) for the overlap between the most significant SV for each eGene and various annotated genomic states. 
(A) Enrichment of SVs in each causality bin for intersections with exons of the affected eGene. (B-P) For the 
remaining plots, SVs that overlapped with an exon of the affected eGenes were excluded. We identified 
genomic intervals where each of the 15 Roadmap Epigenomics segmentation states are found in at least 10 of 
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Supplemental Fig. S5. Distribution of the tissue specificity of eQTLs across tissues, as evaluated by 
METASOFT, for eQTLs in which the activity status is known in at least 43 of 48 evaluated tissues. Red lines 
indicate the distribution of SV-eQTLs that are active in the fraction of evaluated tissues indicated on the x-axis. 
Blue lines indicate the same for SNV- and indel-eQTLs. Solid lines denote coding eQTLs where the eVariant 
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Supplemental Fig. S6. Distribution of eQTLs with unknown status (0.1≤m≤0.9) across the indicated number of 
tissues as evaluated by METASOFT. (A) Distribution for coding SV-eQTLs where the eSV intersects with the 
coding region of the associated eGene. (B) Distribution for coding SNV/indel-eQTLs. (C) Distribution for 
noncoding SV-eQTLs where the eSV does not intersect the coding region of the associated eGene. A large 
number of noncoding SV-eQTLs (1,094/9,274) have unknown status in all 48 tissues evaluated. (D) 
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Supplemental Fig. S7. Distribution of eQTL effect sizes and the standard errors of effect sizes for eQTLs 
evaluated by METASOFT. (A-D) Distribution of eQTL effect sizes (beta) for all eQTLs evaluated by 
METASOFT across all 48 tissues. Coding eSVs (A) have much larger effect sizes compared to coding eSNVs 
and eIndels (B), noncoding eSVs (C) and noncoding eSNVs/eIndels (D). (E-H) Distribution of eQTL effect size 
standard errors for all eQTLs evaluated by METASOFT across all 48 tissues. Both coding eSVs (E) and 
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Supplemental Fig. S8. Fold enrichment of European singleton SVs within the indicated distance of multi-
tissue expression outliers (A) and fold enrichment of multi-tissue outliers within indicated distance of European 
singleton SVs (B). Enrichments calculated between the observed set of 26,289 autosomal multi-tissue outliers 
and 1,000 random permutations of outlier sample names. All included SVs are smaller than 1 Mb in size. Only 
European ancestry samples were included in this analysis. 95% confidence intervals are indicated by the error 























































































Supplemental Fig. S9. Distribution of gene expression outlier effect sizes. The effect sizes for all outliers are 
shown in green. Outliers associated with each SV type are also shown, separated by whether the SV causes a 
complete dosage change (red), partial dosage change (blue) or is noncoding for the associated outlier gene 
(yellow). Effect sizes shown are the most extreme effect size for each outlier gene across all tissues with 
available expression data. Counts below the x-axis indicate the number of unique SV/outlier pairs with the 
indicated SV type. Percentages above distributions indicate the fraction of SV/outlier pairs with the relevant 





















































































Supplemental Fig. S10. Distribution of SV impact scores calculated with SVScore. (A-B) Distribution of mean 
phastCONS scores for outlier-associated (A) and control-associated (B) SVs. (C-D) Distribution of mean 
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Supplemental Fig. S11. Feature enrichment of SV-eQTLs repeated with no additional padding around any 
features. Fold enrichment and 95% confidence intervals (based on 100 random shuffled sets of the positions of 
SVs in each bin) for the overlap between the most significant SV for each eGene and various annotated 
genomic features. (A) Enrichment of SVs in each causality bin for intersections with exons of the affected 
eGene. (B-T) For the remaining plots, SVs that overlapped with an exon of the affected eGenes were 
excluded. As in Supplemental Fig. S3, enrichment was only observed in the 10-kb regions upstream (N) and 
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